We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+16.27%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$218M
AUM Growth
+$31.4M
Cap. Flow
+$20.5M
Cap. Flow %
9.41%
Top 10 Hldgs %
67.74%
Holding
39
New
1
Increased
4
Reduced
1
Closed
6

Top Buys

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$16.2M
2
RGLD icon
Royal Gold
RGLD
+$8.68M
3
SSRM icon
SSR Mining
SSRM
+$5.45M
4
NUVB icon
Nuvation Bio
NUVB
+$2.93M
5
ABEO icon
Abeona Therapeutics
ABEO
+$872K

Top Sells

Rank Stock Value
1
SAND
Sandstorm Gold
SAND
+$8.76M
2
V icon
Visa
V
+$1.66M
3
APLT
Applied Therapeutics
APLT
+$1.11M
4
DEO icon
Diageo
DEO
+$644K
5
MREO
Mereo BioPharma
MREO
+$537K

Sector Composition

Rank Sector Weight
1 Healthcare 55.34%
2 Materials 33.92%
3 Industrials 1.07%
4 Consumer Staples 0.74%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALDX icon
1
Aldeyra Therapeutics
ALDX
$91.7M
$28.4M 13.01%
5,475,516
– –
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$26.3M 12.06%
2,328,602
+1,433,333
+160% +$16.2M
NUVB icon
3
Nuvation Bio
NUVB
$2.24B
$13.4M 6.16%
1,498,591
+473,591
+46% +$2.93M
AVDL
4
DELISTED
Avadel Pharmaceuticals
AVDL
$12.9M 5.93%
600,000
– –
GLD icon
5
SPDR Gold Trust
GLD
$131B
$12.7M 5.82%
32,000
– –
RGLD icon
6
Royal Gold
RGLD
$17.1B
$11.7M 5.38%
52,750
+43,750
+486% +$8.68M
KGC icon
7
Kinross Gold
KGC
$28.5B
$11.5M 5.3%
410,000
– –
ENTX icon
8
Entera Bio
ENTX
$101M
$11.4M 5.23%
5,881,879
– –
MGTX icon
9
MeiraGTx Holdings
MGTX
$1.09B
$9.94M 4.56%
1,250,000
– –
SA
10
Seabridge Gold
SA
$2.8B
$9.38M 4.3%
317,003
– –
AEM icon
11
Agnico Eagle Mines
AEM
$72.6B
$8.94M 4.1%
52,750
– –
OCUL icon
12
Ocular Therapeutix
OCUL
$1.86B
$7.28M 3.34%
600,400
– –
CGAU
13
Centerra Gold
CGAU
$3.22B
$7.15M 3.28%
497,402
– –
SSRM icon
14
SSR Mining
SSRM
$5.57B
$5.37M 2.46%
+245,000
New +$5.45M
PAAS icon
15
Pan American Silver
PAAS
$18.6B
$5.18M 2.38%
100,035
– –
FNV icon
16
Franco-Nevada
FNV
$41.4B
$5.18M 2.38%
25,000
– –
SLV icon
17
iShares Silver Trust
SLV
$28.1B
$5.15M 2.36%
80,000
– –
ELTX icon
18
Elicio Therapeutics
ELTX
$78.8M
$5.02M 2.3%
630,915
– –
ALT icon
19
Altimmune
ALT
$539M
$4.05M 1.86%
1,121,524
– –
TFPM icon
20
Triple Flag Precious Metals
TFPM
$6B
$1.95M 0.9%
58,800
– –
AGI icon
21
Alamos Gold
AGI
$12.4B
$1.93M 0.88%
50,000
– –
CDE icon
22
Coeur Mining
CDE
$15.6B
$1.71M 0.79%
96,132
– –
NEWP
23
New Pacific Metals
NEWP
$833M
$1.7M 0.78%
485,000
– –
ITA icon
24
iShares US Aerospace & Defense ETF
ITA
$14.2B
$1.64M 0.75%
7,650
– –
PM icon
25
Philip Morris
PM
$301B
$1.6M 0.74%
10,000
– –
1
2

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Knoll Capital Management held 39 positions worth $218M, up 17% from $187M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Knoll Capital Management deployed $20.5M of net new capital in Q4 2025, opening 1 new position and adding to 4 existing holdings. Its largest new stake was SSR Mining: 245,000 shares worth $5.37M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 55% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was Applied Therapeutics, an estimated $1.11M trimmed.

  • Knoll Capital Management's largest Q4 2025 buy was SSR Mining: 245,000 shares worth $5.37M.
  • Knoll Capital Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q4 2025, an estimated $16.2M increase.
  • Knoll Capital Management's biggest Q4 2025 reduction was Applied Therapeutics, cutting an estimated $1.11M.
  • Knoll Capital Management fully exited Sandstorm Gold in Q4 2025, selling an estimated $8.76M.
  • Knoll Capital Management's ten largest holdings make up 68% of its $218M portfolio in Q4 2025.
  • Knoll Capital Management opened 1 new position and closed 6 in Q4 2025.
  • Knoll Capital Management's portfolio value rose 17% quarter-over-quarter to $218M.

Based on Knoll Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.